On September 22, Quest Diagnostics fell 6.08% in pre-market trading, trading at $230.0 USD/share, with turnover of $96,500.
Within the Health Care Services sector where Quest Diagnostics belongs, individual stock performance was mixed. Among individual stocks, CVS Health up 0%, Guardant Health up 0.01%, The Cigna Group up 1.11%, Hims & Hers Health down 0.95%, Labcorp Holdings up 0%.
Quest Diagnostics Incorporated is a global leader in diagnostic testing, information, and services. The company develops and delivers diagnostic information services including routine testing, advanced clinical testing, and anatomic pathology testing, primarily under the Quest Diagnostics brand. It serves patients, clinicians, hospitals, health plans, and employers through an extensive network of laboratories and patient service centers across the United States and internationally.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)